quinoxalines has been researched along with Albinism, Oculocutaneous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolinska, MB; Patel, MH; Sergeev, YV | 1 |
| Acheampong, AA; Shackleton, M; Tang-Liu, DD | 1 |
2 other study(ies) available for quinoxalines and Albinism, Oculocutaneous
| Article | Year |
|---|---|
Tyrp1 Mutant Variants Associated with OCA3: Computational Characterization of Protein Stability and Ligand Binding.
Topics: Albinism, Oculocutaneous; Computational Biology; Humans; Ligands; Melanins; Melanocytes; Membrane Glycoproteins; Molecular Docking Simulation; Oxidoreductases; Protein Folding; Protein Stability; Quinoxalines | 2021 |
Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits.
Topics: Adrenergic alpha-Agonists; Albinism, Oculocutaneous; Animals; Brimonidine Tartrate; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Eye; Female; Ophthalmic Solutions; Pigment Epithelium of Eye; Quinoxalines; Rabbits | 1995 |